Private Placement - Joint Global Coordinator and Joint Bookrunner Newron Pharmaceuticals

Newron

Newron Pharmaceuticals is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system and pain.

Placement of 2,000,000 new shares, representing 12.6% of Newron’s pre-deal outstanding share capital
Issue price of CHF 13.50 per share resulting in gross proceeds of CHF 27.0 million
Strong indications of interest were received during a market sounding exercise prior to transaction launch
The accelerated book-building process generated strong demand from US and European Life Sciences specialist and generalist investors, resulting in a multiple times oversubscribed order book
Transaction proceeds will be used for the company’s operations, research programs and the development of the company’s current and future pipeline products with a focus on its schizophrenia drug Evenamide
Kempen acted as Joint Global Coordinator and Joint Bookrunner in this transaction

Ons team

Jan De Kerpel

Lees meer over:

Kapitaalmarkt-transacties

Het Kempen Equity Capital Markets team biedt onafhankelijk advies in het structureren, voorbereiden, op de markt brengen en distribueren van aandelen. We hebben uitgebreide ervaring in Europa in verscheidene transacties, zoals IPOs, follow-on capital increases, secondary offerings, share buy-backs and equity-linked transactions.

Corporate Finance

Corporate Finance en Equity Capital Markets richt zich specifiek op een aantal internationale kernsectoren. Binnen deze sectoren kennen we de investeerders, de bedrijven en zijn we op de hoogte van de laatste ontwikkelingen.

Life Sciences & Healthcare

Kempen Life Sciences & Healthcare is uniek gepositioneerd als een gespecialiseerde adviseur in de life sciences & healthcare sector. Daarbij combineren wij onze diepgaande kennis van de financiële sector met een wetenschappelijke achtergrond en uitgebreide zakelijke ervaring.

Transactions

No transactions found

Accelerated Bookbuild Offering

Initial Public Offering
on Nasdaq

Accelerated Bookbuild Offering

Initial Public Offering on Nasdaq

Initial Public Offering on Nasdaq

Accelerated Bookbuild Offering

Capital increase

Private Placement

US Public Offering

Initial Public Offering

US Public Offering

Accelerated Bookbuild Offering

Accelerated Bookbuild Offering

Initial Public Offering

Debt financing

US Public Offering

US Public Offering

Green Revolving Credit Facility

Sale to

Combination with

Accelerated Bookbuild Offering

Sale to

Accelerated Bookbuild Offering

Non-listed equity capital raising

Sale of majority stake to

Secondary Sell-Down in Calliditas Therapeutics

Capital increase

Initial Public Offering

Capital Increase

European FinTech
IPO

Accelerated Bookbuild Offering

Private Placement of shares in

Bridge financing

Undisclosed

Initial Public Offering

Rights issue

Accelerated Bookbuild Offering

US Public Offering

Accelerated Bookbuild Offering

Public Offering

Merger with Arya Sciences Acquisition Corp. and subsequent Nasdaq listing

acquisition of

Initial Public Offering

Private Placement

Private Placement

Accelerated Bookbuild Offering

Global Accelerated Bookbuild Offering

Accelerated bookbuild offering

Sale of 456 unit landmark residential project in prime location The Hague

acquired by

public offer for

Sale and capital increase

and

Sale of Dutch residential development to

Global Offering

Accelerated Bookbuild Offering

Public takeover of

Private placement of shares

Series C Capital increase

Rights issue

Placement of treasury shares

november 2019

Reggeborgh VolkerWessels Public takeover financing

Sale of

to

Accelerated Bookbuild Offering

Capital increase

Global offering

US public offering

Rights issue

US public offering

Initial Public Offering

Accelerated bookbuild offering

Accelerated bookbuild offering

Initial Public Offering on NASDAQ

Secondary placing of Fagron shares

Rights issue

a subsidiary of

Sale of German DIY portfolio to REDOS acting on behalf of Union Investment

Accelerated bookbuild offering

Accelerated Bookbuild Offering on behalf of selling shareholders in

Three-day bookbuild offering

Rights issue

Acquisition of

Initial Public Offering

Accelerated Bookbuild Offering

Block trade in argenx shares

a subsidiary of

Sale of German retail portfolio to a real estate private equity firm

Sale of Dutch residential portfolio managed by

on behalf of investors to

Sale of

to

Bencis Capital Partners

Increase of stake in

Initial Public Offering

Secondary Offering via ABB in Deutsche Wohnen shares (4.7%)

Accelerated bookbuild offering

Accelerated bookbuild offering

Acquisition of

Acquisition of non-held shares in GRIP

Acquisition of

Acquisition of

Capital increase

Block trade in ERYTECH shares

Initial public offering

Accelerated bookbuild offering

Initial public offering

Acquisition of

Block trade in Boskalis shares

US public offering

US public offering

Sale to

US public offering

Sale of Rabo Bouwfonds CIF datacenter portfolio to

Initial public offering

Acquisition of former Delta Lloyd portfolio from

Rights issue

Series B Capital increase

Public offer for

Global offering

Accelerated bookbuild offering

Fundraise

Accelerated bookbuild offering

Public offer by German listed ADLER Real Estate

for Israeli listed

Public offer by German Vonovia

for German-Austrian Buwog

Rights issue

Accelerated bookbuild offering

Sale of Dynamic Portfolios

Public offer by Spanish Colonial

for Spanish Axiare Real Estate

Accelerated bookbuild offering

Accelerated bookbuild offering

Sale of 3 German residential portfolios by

to consortium of buyers

Accelerated bookbuild offering

US public offering

Accelerated bookbuild offering

Accelerated bookbuild offering

Accelerated bookbuild offering

Accelerated bookbuild offering

Secondary offering

Acquisition by

of

Acquisition of

by

Private placement

Acquisition by

of

Dutch wealth management activities

juli 2017

Inaugural bond issue

Acquisition by

of

from

Initial public offering

Accelerated bookbuild offering

Initial public offering on NASDAQ

Capital raise

Share buy-back program

Share buy-back program

Initial public offering

Capital raise

Acquisition by

of

Accelerated bookbuild offering

Capital increase with priority allocation rights

Rights issue

Secondary placement of 9.4% stake in

Public offer by

for

Public takeover by German Vonovia

For Austrian Conwert

Secondary placement of 15% stake in

Formation of Passoã joint venture with

Accelerated bookbuild offering

Rights issue

Capital increase with priority allocation rights

Sale of 19% stake in

Accelerated bookbuild offering

Accelerated bookbuild offering

Capital increase with priority allocation rights

Rights issue

Acquisition of the North American rights to RUCONEST by

from

Acquisition by

of

from

juli 2016

Strategic study

Secondary placement 30% stake in

Share buy-back program

Direct share placement

Initial public offering

Accelerated bookbuild offering

Private placement

Strategic study

Placement of treasury shares

Sale of the European veterinary business of

to

Strategic study

Private placement

Placement of treasury shares

Public offer for Deutsche Office

By German Alstria

Accelerated bookbuild offering

Public offer for

Initial public offering

Rights issue

Rights issue

Initial public offering

Rights issue

Sale of

to

Residential portfolio sale by Dekor

A company owned by Reggeborgh

Rights issue

Accelerated bookbuild offering

Secondary placement of 35% stake in IOW

Accelerated bookbuild offering

Refinancing

Rights issue

Refinancing

Capital Raise

Initial public offering

Capital restructuring

maart 2015

Acquisition by

of

Management participation advisory in dual-track sale process

Refinancing

Initial Public Offering

Initial public offering

Rights issue

On behalf of

sale of majority of shares in

Acquisition of

Rights issue

Acquisition of French shopping centre portfolio by Wereldhave

From French-Dutch Unibail-Rodamco

Refinancing

Initial public offering

Acquisition of the cancer immunotherapy program by

from

Initial public offering

Initial public offering

Public offer by French Groupe SMABTP

For French Société de la Tour Eiffel

Acquisition of

by

Secondary offering

juli 2014

Secondary listing on Euronext Paris

Initial public offering

juli 2014

Acquisition by

of

Accelerated bookbuild offering

Convertible bond issue

Fairness opinion in the public offer by

Sale of shares to

and the Koole family

Sale of Hercules business to ZEG

Refinancing

Convertible bond issue

Initial public offering

Sale of Dutch supply assets to

Accelerated bookbuild, preference shares issue and refinancing

Acquisition of

by

undisclosed PE firm

from

At-market rights issue

Acquisition by

of

Accelerated bookbuild offering

Private placement by acquisition vehicle for French Carrefour

november 2013

Secondary offering

Combined offering of primary and secondary shares

Public offer for German listed GSW

by German listed

Initial Public Offering

Equity issue

Refinancing

Sale of majority of shares to

Accelerated bookbuild offering

Initial public offering

Initial public offering

juni 2013

Secondary offering

Accelerated bookbuild offering

Public offer by

for

Private placement

Public offer by

for

Accelerated bookbuild and private placement

Initial public offering

januari 2013

Rights issue